Efthymios Deliargyris
2019
In 2019, Efthymios Deliargyris earned a total compensation of $801.7K as Former Chief Medical Officer at Dipexium Pharmaceuticals, a 85% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $190,000 |
|---|---|
| Option Awards | $245,400 |
| Salary | $353,750 |
| Other | $12,500 |
| Total | $801,650 |
Deliargyris received $353.8K in salary, accounting for 44% of the total pay in 2019.
Deliargyris also received $190K in non-equity incentive plan, $245.4K in option awards and $12.5K in other compensation.
Rankings
In 2019, Efthymios Deliargyris' compensation ranked 10,207th out of 13,971 executives tracked by ExecPay. In other words, Deliargyris earned more than 26.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,207 out of 13,971 | 27th |
Division Manufacturing | 4,123 out of 5,692 | 28th |
Major group Chemicals And Allied Products | 1,568 out of 2,189 | 28th |
Industry group Drugs | 1,342 out of 1,875 | 28th |
Industry Pharmaceutical Preparations | 998 out of 1,387 | 28th |
Source: SEC filing on September 25, 2020.
Deliargyris' colleagues
We found three more compensation records of executives who worked with Efthymios Deliargyris at Dipexium Pharmaceuticals in 2019.